Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06791772
What this trial is testing

Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)

Who this might be right for
Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd 150
Early research (Phase 1)Looking for participantsNCT06340750
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Luminary Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT03312335
What this trial is testing

Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Onur Boyman, MD 16
Not applicableUnknownNCT05900232
What this trial is testing

Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04736953
What this trial is testing

Sirolimus Treatment Of Patients With SLE

Who this might be right for
Lupus Erythematosus, Systemic
State University of New York - Upstate Medical University 220
Not applicableNot Yet RecruitingNCT07136337
What this trial is testing

The Diagnostic Utility of T Immunoglobulin G and T Immunoglobulin M Biomarkers in Patients With Systemic Lupus Erythematosus Disease : Associations With Disease Activity and Damage

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 80
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Testing effectiveness (Phase 2)Study completedNCT04925934
What this trial is testing

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Who this might be right for
Lupus Erythematosus, Systemic
Amgen 214
Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Not applicableStudy completedNCT02782039
What this trial is testing

Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)

Who this might be right for
Anti-Phospholipids Syndrome (APS)Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 868
Large-scale testing (Phase 3)Study completedNCT03616964
What this trial is testing

Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

Who this might be right for
Systemic Lupus Erythematosus
Eli Lilly and Company 778
Large-scale testing (Phase 3)Study completedNCT01345253
What this trial is testing

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 709
Large-scale testing (Phase 3)Ended earlyNCT00368264
What this trial is testing

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Medical University of Vienna 1
Testing effectiveness (Phase 2)WithdrawnNCT00752999
What this trial is testing

Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Rigel Pharmaceuticals
Not applicableStudy completedNCT03019926
What this trial is testing

Lupus and Observance

Who this might be right for
Systemic Lupus, Skin Lupus
University Hospital Center of Martinique 200
Not applicableStudy completedNCT00235378
What this trial is testing

Genetic Study of Lupus Patients and Their Families

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 2,356
Not applicableStudy completedNCT01549184
What this trial is testing

Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaSystemic Lupus Erythematosus
Henri Mondor University Hospital 40
Post-approval studies (Phase 4)UnknownNCT04127747
What this trial is testing

Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus

Who this might be right for
Autoimmune Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine 110
Large-scale testing (Phase 3)WithdrawnNCT04060888
What this trial is testing

Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Janssen Research & Development, LLC
Not applicableStudy completedNCT04098055
What this trial is testing

Effect of Insoles in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, SystemicFoot OrthosesMusculoskeletal Pain
University of Seville 40
Next Page